Neuphoria Therapeutics Inc 20-F for FY2023
Neuphoria Therapeutics Inc. (NEUP)
20-F
2023-10-18
For: 2023-06-30
View Original
Added on
April 07, 2026
About this 20-F
Neuphoria Therapeutics Inc filed this 20-F on October 18, 2023, covering the fiscal year ended June 30, 2023 (FY2023).
Headline figures
Fiscal year ended June 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 22.05K AUD
- down 91.6% from 263.63K AUD a year earlier
- Net loss
- 31.85M AUD
- compared with a net loss of 21.76M AUD a year earlier
- Diluted EPS
- -0.02 AUD
- compared with -0.02 AUD a year earlier